KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Change in Cash (2016 - 2025)

Resmed (RMD) has disclosed Change in Cash for 17 consecutive years, with $33.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash fell 65.24% year-over-year to $33.2 million, compared with a TTM value of $895.1 million through Dec 2025, up 187.18%, and an annual FY2025 reading of $971.1 million, up 9174.97% over the prior year.
  • Change in Cash was $33.2 million for Q4 2025 at Resmed, down from $174.4 million in the prior quarter.
  • Across five years, Change in Cash topped out at $410.8 million in Q1 2025 and bottomed at -$81.7 million in Q4 2021.
  • Average Change in Cash over 5 years is $58.1 million, with a median of $17.5 million recorded in 2022.
  • The sharpest move saw Change in Cash tumbled 446.98% in 2023, then surged 61261.2% in 2025.
  • Year by year, Change in Cash stood at -$81.7 million in 2021, then surged by 156.37% to $46.0 million in 2022, then tumbled by 97.51% to $1.1 million in 2023, then soared by 8233.3% to $95.6 million in 2024, then tumbled by 65.24% to $33.2 million in 2025.
  • Business Quant data shows Change in Cash for RMD at $33.2 million in Q4 2025, $174.4 million in Q3 2025, and $276.7 million in Q2 2025.